Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2022-01-21 00:00:00 ET · period of report 2022-01-19 · accession 0001055726-22-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-21 | 2022-01-19 | INO | BENITO SIMON X | Dir | M - OptEx | $2.20 | +2,000 | 59.3K | +3% | +$4,400 |
| D | 2022-01-21 | 2022-01-19 | INO | BENITO SIMON X | Dir | S - Sale+OE | $4.27 | -2,000 | 57.3K | -3% | -$8,540 |
| D | 2022-01-21 | 2022-01-19 | INO | BENITO SIMON X | Dir | M - OptEx | $0.00 | -2,000 | 8,000 | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-19 | M | A | 2,000 | $2.20 | 59,305 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-19 | S | D | 2,000 | $4.27 | 57,305 | D | — | — | |
| 3 | Derivative | Common Stock Options | 2022-01-19 | M | D | 2,000 | $0.00 | 8,000 | D | $2.20 · 2012-08-10 to 2022-08-10 | 2,000 Common Stock | (F2) Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014. |